Neoventa introduces unique fetal heart monitor to the U.S. market

The U.S. Food and Drug Admistration (FDA) has approved the STAN® S31 Fetal heart monitor Pre-Market Approval (PMA) application. STAN from Neoventa Medical is the first fetal monitor proven to reduce the risk of brain injury during labor.

Read more

FDA Advisory Panel Unanimously Recommends Approval of the STAN Fetal heart monitor from Neoventa Medical

The U.S. Food and Drug Administration’s (FDA) Obstetrics and Gynecology Advisory Panel voted Thursday to recommend approval of the STAN® S31 Fetal heart monitor Pre-Market Approval (PMA) application. STAN helps clinicians identify babies at risk due to oxygen deficiency during labor. It also reduces the number of unnecessary operative interventions.

Read more
Page 10 of 10 «...678910

# #